Olajugba Oluwaseun J, Oladeji Emmanuel O, Adesola Damilola, Abdullateef Ridwanullah O, Rockson Godwin, Bah Abdul K, Olayode Oluwatobi O
Trauma and orthopaedics, Surgery Interest Group of Africa, Lagos 105101, Nigeria.
Ecancermedicalscience. 2025 Jan 23;19:1835. doi: 10.3332/ecancer.2025.1835. eCollection 2025.
Osteosarcoma has the highest incidence among individuals of African descent, with growing evidence suggesting ethnic and racial genetic underpinning. Hence, it presents a grave public health challenge in Africa given the widening inequities in access to cancer care. This scoping review addresses the critical gap in the availability of locally relevant data on the magnitude of the burden and challenges relating to the management and outcome of African centres. This study included 1,374 patients from eighteen studies. 81% presented with locally advanced or metastatic disease. While surgical treatment for osteosarcoma is shifting toward limb salvage on a global scale, amputation remains preponderant in Africa as only 53% underwent limb salvage operations. The pooled 5-year overall survival was 49.1%. Late presentation, workforce and infrastructural shortage, cultural beliefs, patronage of unorthodox medicine practitioners and high healthcare costs were the barriers driving poor outcomes in African centres. Strategies to improve outcomes should focus on addressing these barriers.
骨肉瘤在非洲裔人群中发病率最高,越来越多的证据表明存在种族和民族的遗传基础。因此,鉴于癌症护理可及性方面日益扩大的不平等现象,骨肉瘤在非洲构成了严峻的公共卫生挑战。本范围综述解决了非洲各中心在骨肉瘤负担规模以及管理和治疗结果相关挑战方面缺乏本地相关数据这一关键差距。本研究纳入了18项研究中的1374例患者。81%的患者表现为局部晚期或转移性疾病。虽然全球范围内骨肉瘤的外科治疗正朝着保肢方向转变,但截肢在非洲仍然占主导地位,因为只有53%的患者接受了保肢手术。汇总的5年总生存率为49.1%。就诊延迟、劳动力和基础设施短缺、文化信仰、对非正统医学从业者的追捧以及高昂的医疗费用是导致非洲各中心治疗效果不佳的障碍。改善治疗效果的策略应侧重于解决这些障碍。